FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to a cryopreservant cryopreservation composition for long-term storage of primary keratinocytes. Cryopreservant contains DMEM/F12 nutrient medium, additionally contains Panexin NTA serum substitute, cryoprotector DMSO and alpha-lipoic acid in concentration of 200 mcM, dissolved in DMSO, with following ratio of ingredients, %: DMEM/F12 nutrient medium – 70–75 %; Panexin NTA serum replacer – 10–15 %; cryoprotector DMSO – 9.999 %; alpha-lipoic acid – 0.001 %, wherein the increase in the portion of the Panexin NTA serum substitute in the final solution occurs by reducing the portion of the DMEM/F12 nutrient medium.
EFFECT: invention increases output of live and active to human keratinocytes from deep freezing after prolonged storage.
1 cl, 1 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
HUMAN BLADDER CANCER CELL LINE 587 BLCAN TVV | 2020 |
|
RU2742244C1 |
HUMAN BLADDER CANCER CELL LINE 398 BLCAN KAE | 2020 |
|
RU2742245C1 |
HUMAN COLORECTAL CANCER CELL LINE 485 COLO CAN | 2017 |
|
RU2650757C1 |
HUMAN BLADDER CANCER CELL LINE 198 BLCAN RLA | 2019 |
|
RU2733230C1 |
HUMAN BLADDER CANCER CELL LINE 190 BICAN KAG | 2021 |
|
RU2779948C1 |
METHOD FOR CELL CRYOPRESERVATION, ARTIFICIAL CELL CONSTRUCTS OR THREE-DIMENSIONAL TISSUE COMPLEXES | 2010 |
|
RU2573307C2 |
HUMAN OVARIAN CANCER CELL LINE 533 OOS | 2017 |
|
RU2650759C1 |
METHOD OF CRYOCONSERVATION OF MULTIPOTENT MESENCHYMAL STROMAL CELLS | 2010 |
|
RU2433173C1 |
APPLICATION OF HUMAN SKIN MELANOMA CELL LINE 388mel | 2018 |
|
RU2675541C1 |
APPLICATION OF CELL LINE OF RC291C CLEAR CELL ADENOCARCINOMA | 2018 |
|
RU2673729C1 |
Authors
Dates
2020-08-28—Published
2019-12-24—Filed